Several asian nations will experience significant economic damage from the coronavirus, according to forecasts by Standard & Poor's.
Japanese company Shionogi developed a noninvasive saliva test for Covid-19 that delivers results in 25 minutes, and could be used on travelers.
In Japan investors have priced in earnings a full six months too soon, while in China the coronavirus stages a bit of a comeback.
Sentiment is getting a bit too bullish and we're overbought, and here's what that should mean.
The surprise abandonment of a Japan project by Las Vegas Sands is just the latest indication of how red tape is turning suitors away.
India's drugmakers aim to manufacture generic versions of any coronavirus 'cure', even before the full findings as to how effective they are.
Slowing infections in South Korea and stimulus in Singapore and Japan pushed stocks higher Monday, but tighter restrictions will hurt Asia's economies.
With Tokyo's coronavirus case count accelerating, investors are bracing themselves in case the still-bustling capital goes into lockdown.
Japan is a leader in pharmaceuticals and has three companies working overtime to develop treatments for Covid-19.
Fujifilm Holdings has a promising drug that seems to work in improving the outcome for coronavirus patients in China and Japan, though Avigan is a treatment not a cure.